BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38654325)

  • 1. Tumor-suppressive miR-4732-3p is sorted into fucosylated exosome by hnRNPK to avoid the inhibition of lung cancer progression.
    Zhuang W; Liu C; Hong Y; Zheng Y; Huang M; Tang H; Zhao L; Huang Z; Tu M; Yu L; Chen J; Zhang Y; Chen X; Lin F; Gao Q; Yu C; Huang Y
    J Exp Clin Cancer Res; 2024 Apr; 43(1):123. PubMed ID: 38654325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
    Duan Z; Wei S; Liu Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis.
    Ning Z; Tian Y; Li Y; Zhao X; Zhang J; Wang C; Hu J; Shen H; Wu W
    Anticancer Drugs; 2022 Jan; 33(1):61-74. PubMed ID: 34620741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
    Hu C; Zou Y; Jing LL
    J Biosci; 2020; 45():. PubMed ID: 32345774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B; Li J; Zheng M; Ge J; Li J; Yu P
    Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
    Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
    Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
    Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-1915-3p inhibits cell migration and invasion by targeting SET in non-small-cell lung cancer.
    Pan H; Pan Z; Guo F; Meng F; Zu L; Fan Y; Li Y; Li M; Du X; Zhang X; Shao Y; Wei M; Li X; Zhou Q
    BMC Cancer; 2021 Nov; 21(1):1218. PubMed ID: 34774019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
    Chen J; Ding C; Yang X; Zhao J
    J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-376b-3p functions as a tumor suppressor by targeting KLF15 in non-small cell lung cancer.
    Liu XW; Zhang CC; Zhang T
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9480-9486. PubMed ID: 33015790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly expressed lncRNA FOXD3-AS1 promotes non-small cell lung cancer progression via regulating miR-127-3p/mediator complex subunit 28 axis.
    Zeng ZL; Zhu HK; He LF; Xu X; Xie A; Zheng EK; Ni JJ; Liu JT; Zhao GF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2525-2538. PubMed ID: 32196603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.